Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a combination product containing omeprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection. Omeprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
## Primary Indications
Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
**Standard Regimen:**
* Omeprazole 20 mg orally twice daily
* Amoxicillin 1000 mg orally twice daily
* Clarithromycin 500 mg orally twice daily
**Duration:** 10 to 14 days. The exact duration may depend on local guidelines and patient factors.
## Pediatric Dosing
Specific dosing for pediatric patients is not established for this fixed-dose combination product. Dosing for individual components would need to be calculated based on weight and age, with careful consideration of the risks and benefits.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment for the standard regimen. However, caution may be advised in severe hepatic impairment.
## Contraindications
* Hypersensitivity to omeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of severe hypersensitivity to beta-lactam antibiotics (e.g., anaphylaxis to penicillin).
* History of cholestatic jaundice/hepatic dysfunction associated with prior macrolide exposure.
* Concomitant use with ergotamine derivatives.
## Adverse Effects
**Common:** Diarrhea, nausea, abdominal pain, taste disturbance, headache, rash.
**Serious:** *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions (including anaphylaxis), liver dysfunction, QT prolongation (clarithromycin), *Stevens-Johnson syndrome*, *toxic epidermal necrolysis*.
## Key Drug Interactions
* **Clarithromycin:**
* CYP3A4 substrates (e.g., statins, warfarin, certain antiarrhythmics, benzodiazepines): increased levels and risk of toxicity.
* Colchicine: increased colchicine levels.
* Ergotamine and dihydroergotamine: risk of ergotism.
* Theophylline: increased theophylline levels.
* **Omeprazole:**
* CYP2C19 and CYP3A4 substrates (e.g., clopidogrel, diazepam, phenytoin, warfarin): may alter levels.
* Ketoconazole, itraconazole: decreased absorption.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for diarrhea, especially *C. difficile*-associated diarrhea.
* Assess for resolution of ulcer symptoms and *H. pylori* eradication (e.g., urea breath test, stool antigen test) after therapy completion.
* Liver function tests may be considered in patients with pre-existing liver disease or if signs of hepatic dysfunction develop.
## Clinical Pearls
* This combination therapy should be administered for the full prescribed duration to maximize eradication rates and minimize resistance.
* Patients should be instructed to take amoxicillin and clarithromycin with food to improve tolerability. Omeprazole should be taken before a meal.
* Consider alternative regimens if penicillin allergy is present or if there is a known allergy to macrolides.
* Resistance to clarithromycin is increasing and can impact treatment efficacy.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and specific institutional protocols before making treatment decisions. Drug information can change rapidly.
